145 related articles for article (PubMed ID: 3152936)
1. Intraocular involvement of Burkitt's lymphoma in a Bedouin child.
Wysenbeek YS; Nissenkorn I; Cohen S; Ben-Sira I; Stark B; Zaizov R
Pediatr Hematol Oncol; 1987; 4(4):309-14. PubMed ID: 3152936
[TBL] [Abstract][Full Text] [Related]
2. Primary Burkitt's lymphoma of the ovary.
Cyriac S; Srinivas L; Mahajan V; Sundersingh S; Sagar TG
Afr J Paediatr Surg; 2010; 7(2):120-1. PubMed ID: 20431226
[No Abstract] [Full Text] [Related]
3. Intensive chemotherapy in patients with generalized Burkitt's lymphoma.
Ziegler JL; Bluming AZ; Magrath IT; Carbone PP
Int J Cancer; 1972 Sep; 10(2):254-61. PubMed ID: 4574467
[No Abstract] [Full Text] [Related]
4. [Long-lasting remission of Burkitt's disease in African children. Apropos of 6 cases].
Plo JK; Rain JD; Andoh J; Tea DN; Essoh NP
Med Trop (Mars); 1986; 46(2):141-6. PubMed ID: 3724411
[TBL] [Abstract][Full Text] [Related]
5. [Reye syndrome in a child having received chemotherapy].
Dubern B; Alessandri JL; Montbrun A; Attali T; Pilorget H; Samperiz S
Arch Pediatr; 1998 Mar; 5(3):342-3. PubMed ID: 10328010
[No Abstract] [Full Text] [Related]
6. Effectiveness of moderate dose combination chemotherapy in Burkitt's lymphoma.
Patel JG; Pandita R; al-Jazzaf H; Mechl Z; al-Jarallah MA
Neoplasma; 1993; 40(3):185-8. PubMed ID: 8350967
[TBL] [Abstract][Full Text] [Related]
7. Intensive, very short-term chemotherapy for advanced Burkitt's lymphoma in children.
Spreafico F; Massimino M; Luksch R; Casanova M; Cefalo GS; Collini P; Ferrari A; Polastri D; Terenziani M; Gasparini M; Fossati-Bellani F
J Clin Oncol; 2002 Jun; 20(12):2783-8. PubMed ID: 12065554
[TBL] [Abstract][Full Text] [Related]
8. Burkitt's lymphoma presenting with blindness: a case report.
Ibrahim M; Ogala WN; Babaoye FA; Onabolu OO; Afolayan EA
Ann Trop Paediatr; 1990; 10(3):319-22. PubMed ID: 1703753
[TBL] [Abstract][Full Text] [Related]
9. [Burkitt lymphoma. Study of 110 patients].
Oji C; Ike I
Mund Kiefer Gesichtschir; 1999 Jul; 3(4):220-4. PubMed ID: 10474269
[TBL] [Abstract][Full Text] [Related]
10. Favorable response of pediatric AIDS-related Burkitt's lymphoma treated by aggressive chemotherapy.
Neumann Y; Toren A; Mandel M; Martinowitz U; Varon D; Ramot B; Ben-Bassat I; Rechavi G
Med Pediatr Oncol; 1993; 21(9):661-4. PubMed ID: 8413000
[TBL] [Abstract][Full Text] [Related]
11. HiC-COM: a 2-month intensive chemotherapy regimen for children with stage III and IV Burkitt's lymphoma and B-cell acute lymphoblastic leukemia.
Schwenn MR; Blattner SR; Lynch E; Weinstein HJ
J Clin Oncol; 1991 Jan; 9(1):133-8. PubMed ID: 1985162
[TBL] [Abstract][Full Text] [Related]
12. African Burkitt's lymphoma: case report and light and electron microscopic findings.
Yih WY; Myers SL; Meshul CK; Bartley MH
Oral Surg Oral Med Oral Pathol; 1990 Dec; 70(6):760-4. PubMed ID: 2263336
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of Burkitt lymphoma and Burkitt-like lymphoma].
Maruyama D
Rinsho Ketsueki; 2011 Oct; 52(10):1645-54. PubMed ID: 21971242
[No Abstract] [Full Text] [Related]
14. Burkitt's lymphoma in a 45-year-old Nigerian woman.
Lawal OO; Ojo OS; Durosinmi MA
Trop Geogr Med; 1990 Jul; 42(3):294-7. PubMed ID: 2293442
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes of AIDS-related Burkitt lymphoma: a multi-institution retrospective survey in Japan.
Kojima Y; Hagiwara S; Uehira T; Ajisawa A; Kitanaka A; Tanuma J; Okada S; Nagai H
Jpn J Clin Oncol; 2014 Apr; 44(4):318-23. PubMed ID: 24558129
[TBL] [Abstract][Full Text] [Related]
16. Severe central nervous adverse effect of intrathecal chemotherapy in a 16-yr-old patient with Burkitt's type lymphoma.
Geissler RG; Bergmann L; Hacker H; Knupp B; Walker B; Hoelzer D
Eur J Haematol; 1997 Apr; 58(4):286-8. PubMed ID: 9186541
[No Abstract] [Full Text] [Related]
17. Treatment of Burkitt lymphoma in equatorial Africa using a simple three-drug combination followed by a salvage regimen for patients with persistent or recurrent disease.
Ngoma T; Adde M; Durosinmi M; Githang'a J; Aken'Ova Y; Kaijage J; Adeodou O; Rajab J; Brown BJ; Leoncini L; Naresh K; Raphael M; Hurwitz N; Scanlan P; Rohatiner A; Venzon D; Magrath I
Br J Haematol; 2012 Sep; 158(6):749-62. PubMed ID: 22844968
[TBL] [Abstract][Full Text] [Related]
18. Skin involvement in Burkitt's lymphoma.
Thakkar D; Lipi L; Misra R; Yadav SP
Hematol Oncol Stem Cell Ther; 2018 Dec; 11(4):251-252. PubMed ID: 29397332
[TBL] [Abstract][Full Text] [Related]
19. Salvage treatment with etoposide (VP-16), ifosfamide and cytarabine (Ara-C) for patients with recurrent primary central nervous system lymphoma.
Arellano-Rodrigo E; López-Guillermo A; Bessell EM; Nomdedeu B; Montserrat E; Graus F
Eur J Haematol; 2003 Apr; 70(4):219-24. PubMed ID: 12656744
[TBL] [Abstract][Full Text] [Related]
20. Results of treatment of advanced-stage Burkitt's lymphoma and B cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine.
Murphy SB; Bowman WP; Abromowitch M; Mirro J; Ochs J; Rivera G; Pui CH; Fairclough D; Berard CW
J Clin Oncol; 1986 Dec; 4(12):1732-9. PubMed ID: 3491184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
